The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,652.50
Bid: 1,652.00
Ask: 1,652.50
Change: 37.50 (2.32%)
Spread: 0.50 (0.03%)
Open: 1,631.00
High: 1,663.50
Low: 1,630.50
Prev. Close: 1,615.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European stocks head for worst week since March

Fri, 23rd Jun 2023 07:42

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

EUROPEAN STOCKS HEAD FOR WORST WEEK SINCE MARCH (0638 GMT)

European futures are heading for their worst week of losses since March's banking turmoil.

Futures on the Eurostoxx are down 0.4% while Germany's DAX futures are falling 0.6%. FTSE futures are down 0.2%.

The STOXX 600 has already shed 2.6% this week as investors digested more interest rate hikes from central banks and the prospect of higher inflation for longer.

Investors are ramping up their bets on a UK recession after the Bank of England delivered a 50 bps hike on Thursday. Even so, British retail sales unexpectedly rose in May.

Meanwhile Japan's core consumer inflation exceeded forecasts in May and an index excluding fuel costs rose at the fastest annual pace in 42 years. The Fed's Powell said on Thursday the central bank would move interest rates at a "careful pace" from here.

Eyes will be on French smart label maker SES Imagotag, whose shares were suspended on Thursday after a shortselling report on its accounts that the company rejected. Italy's Eni , together with its Norwegian unit Var, agreed to buy private-equity backed Neptune Energy in a $4.9 billion deal.

GSK Plc will also be in the spotlight after the British pharmaceutical company said it reached a confidential settlement of a litigation in the United States over claims its heartburn drug Zantac caused cancer.

(Lucy Raitano)

FRAGILE MARKETS WAIT ON PMIS (0622 GMT)

A red tide swept over Asia-session screens on Friday as markets took a hot Japanese inflation reading and the Bank of England's super-sized rate hike as bad news for growth.

Japan's Nikkei looks set to snap a 10-week winning streak and the MSCI Asia ex-Japan index was poised for its worst week of the year, as rates and inflation look higher for longer.

The yen earned some reprieve, but it's shaky and at 143 to the dollar is firmly in intervention-watch territory.

Sterling had already failed to hold on to much of the boost from the Old Lady of Threadneedle Street's hawkish turn, as bond markets see the economic fallout from high rates being deleterious, and it slid further against a rising dollar on Friday.

The Aussie, a growth bellwether, is quickly unwinding a two-week rally and Aussie stocks are down 3% in three days.

The sour turn leaves markets in a delicate spot ahead of global purchasing managers' index surveys due through the day.

Softening is already broadly expected, but, in this sort of mood, any surprise could be taken badly, as solid numbers may only augur more hikes and higher rates. British retail sales figures are also due and expected to show contraction.

Chinese markets were closed on Friday for a holiday, but FTSE China futures were down almost 1% and an early-month rally on stimulus hopes has all but faded away, leaving investors feeling besieged by bad news.

In emerging markets, it's a long way to the weekend for the Turkish Lira which is crumbling as a 650 basis point rate hike on Thursday fell far short of market expectations and was seen as a sign of the political limits on monetary policy.

Key developments that could influence markets on Friday:

Europe, UK and U.S. PMIs

UK Retail Sales

(Tom Westbrook)

More News
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.